• Company
    • About Us
    • Careers
  • Resources
  • Publications
  • News
  • Podcasts
Logo Logo Logo Logo Logo
  • Company
    • About Us
    • Careers
  • Resources
  • Publications
  • News
  • Podcasts
  • Company

    • About Us
    • Careers
  • Resources
  • Publications
  • News
  • Podcasts

Press Release

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • ALL
May 21, 2023
The CorVista® Analysis provides a supervised machine-learned algorithm to IDENTIFY PH patients with New Onset Symptoms

November 17, 2022
The CorVista® Analysis provides a robust prediction for elevated left ventricular end diastolic pressure at the point of-care

October 26, 2022
CorVista Health receives Breakthrough Device Designation for The CorVista® System

June 8, 2022
CorVista Health Announces Drs. Vallerie V. McLaughlin and Mark G. Rabbat Join Medical Advisory Board
1 2 … 6

“CAUTION – The CorVista® System is an investigational device limited by Federal (or United States) law to investigational use and is not available for commercial distribution. The CorVista® System is developed and manufactured by Analytics 4 Life® and licensed exclusively to CorVista® Health”

  • Company
    • About Us
    • Careers
  • Info Pages
    • Resources
    • Publications
    • News
    • Podcasts

© 2019 CorVista® Health, Inc.

Terms of Use
Privacy Policy